4//SEC Filing
Mehalick David 4
Accession 0001683168-23-008778
CIK 0001759186other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 4:01 PM ET
Size
5.3 KB
Accession
0001683168-23-008778
Insider Transaction Report
Form 4
Mehalick David
DirectorCEO and President10% Owner
Transactions
- Gift
Common Stock
2023-12-07−700,000→ 2,757,561 total
Footnotes (1)
- [F1]The listed shares were transferred to an estate planning trust that has an independent trustee, for the benefit of the Reporting Person's children and for no consideration. The Reporting Person does not serve as trustee of this trust nor does he have or share investment control over the listed shares held by this trust. The Reporting Person disclaims beneficial ownership of the shares held by the trust, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the listed shares for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.
Documents
Issuer
Coeptis Therapeutics Holdings, Inc.
CIK 0001759186
Entity typeother
Related Parties
1- filerCIK 0001846623
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 4:01 PM ET
- Size
- 5.3 KB